View in EDS

Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastoma.

Saved in:
Bibliographic Details
Title: Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastoma.
Authors: Liu Z; Department of Laboratory Medicine, Division of Therapeutic Immunology, Karolinska Institutet, Stockholm, Sweden., Rao M; Department of Laboratory Medicine, Division of Therapeutic Immunology, Karolinska Institutet, Stockholm, Sweden., Poiret T; Department of Laboratory Medicine, Division of Therapeutic Immunology, Karolinska Institutet, Stockholm, Sweden.; Centre for Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden., Nava S; Department of Laboratory Medicine, Division of Therapeutic Immunology, Karolinska Institutet, Stockholm, Sweden., Meng Q; Department of Laboratory Medicine, Division of Therapeutic Immunology, Karolinska Institutet, Stockholm, Sweden., von Landenberg A; Department of Laboratory Medicine, Division of Therapeutic Immunology, Karolinska Institutet, Stockholm, Sweden., Bartek J Jr; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden.; Department of Clinical Neuroscience and Department of Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Neurosurgery, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark., Xie S; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden., Sinclair G; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden., Peredo I; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden., Dodoo E; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden., Maeurer M; Department of Laboratory Medicine, Division of Therapeutic Immunology, Karolinska Institutet, Stockholm, Sweden.; Centre for Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Source: Oncotarget [Oncotarget] 2017 Aug 16; Vol. 8 (46), pp. 80208-80222. Date of Electronic Publication: 2017 Aug 16 (Print Publication: 2017).
Publication Type: Journal Article
Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29113296
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Liu+Z%22">Liu Z</searchLink>; Department of Laboratory Medicine, Division of Therapeutic Immunology, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Rao+M%22">Rao M</searchLink>; Department of Laboratory Medicine, Division of Therapeutic Immunology, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Poiret+T%22">Poiret T</searchLink>; Department of Laboratory Medicine, Division of Therapeutic Immunology, Karolinska Institutet, Stockholm, Sweden.; Centre for Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Nava+S%22">Nava S</searchLink>; Department of Laboratory Medicine, Division of Therapeutic Immunology, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Meng+Q%22">Meng Q</searchLink>; Department of Laboratory Medicine, Division of Therapeutic Immunology, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22von+Landenberg+A%22">von Landenberg A</searchLink>; Department of Laboratory Medicine, Division of Therapeutic Immunology, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Bartek+J+Jr%22">Bartek J Jr</searchLink>; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden.; Department of Clinical Neuroscience and Department of Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Neurosurgery, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Xie+S%22">Xie S</searchLink>; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Sinclair+G%22">Sinclair G</searchLink>; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Peredo+I%22">Peredo I</searchLink>; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Dodoo+E%22">Dodoo E</searchLink>; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Maeurer+M%22">Maeurer M</searchLink>; Department of Laboratory Medicine, Division of Therapeutic Immunology, Karolinska Institutet, Stockholm, Sweden.; Centre for Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101532965%22">Oncotarget</searchLink> [Oncotarget] 2017 Aug 16; Vol. 8 (46), pp. 80208-80222. <i>Date of Electronic Publication: </i>2017 Aug 16 (<i>Print Publication: </i>2017).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Impact+Journals%22">Impact Journals </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101532965 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1949-2553 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219492553%22">19492553 </searchLink><i>NLM ISO Abbreviation: </i>Oncotarget <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29113296
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.18632/oncotarget.20303
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 80208
    Titles:
      – TitleFull: Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Liu Z
      – PersonEntity:
          Name:
            NameFull: Rao M
      – PersonEntity:
          Name:
            NameFull: Poiret T
      – PersonEntity:
          Name:
            NameFull: Nava S
      – PersonEntity:
          Name:
            NameFull: Meng Q
      – PersonEntity:
          Name:
            NameFull: von Landenberg A
      – PersonEntity:
          Name:
            NameFull: Bartek J Jr
      – PersonEntity:
          Name:
            NameFull: Xie S
      – PersonEntity:
          Name:
            NameFull: Sinclair G
      – PersonEntity:
          Name:
            NameFull: Peredo I
      – PersonEntity:
          Name:
            NameFull: Dodoo E
      – PersonEntity:
          Name:
            NameFull: Maeurer M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 08
              Text: 2017 Aug 16
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-electronic
              Value: 1949-2553
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 46
          Titles:
            – TitleFull: Oncotarget
              Type: main
ResultId 1